Johannes Blom, MD
Adult Reconstructive Orthopaedic Surgery · Hollywood, FLNPI 1184654519
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Amgen at 44.8% of the total. Reporting peaked in 2019 at $148 and has fallen 75.2% since, to $37 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in FL, where the typical reported total is $11,822.
Across 17 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$135
- Johnson & Johnson$54
- Smith+Nephew$37
- DJO, LLC$26
- Vertex$22
- Coastal Medical Technologies LLC$15
- plus $14 from 1 others
What the payments were for
- Food & beverage$302100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 9 | $135 |
| Johnson & Johnson | 2 | $54 |
| Smith+Nephew | 2 | $37 |
| DJO, LLC | 1 | $26 |
| Vertex | 1 | $22 |
| Coastal Medical Technologies LLC | 1 | $15 |
| Linvatec Corporation | 1 | $14 |
How this compares
$302 in reported general payments places this provider in the 10th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 287 | $6,179 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 26 | $642 |
| Tizanidine Hcl | 88 | $408 |
| Diclofenac Sodium | 25 | $348 |
| Tramadol Hcl | 121 | $257 |
| Methylprednisolone | 36 | $197 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 47 | $192 |
| Ibuprofen | 29 | $151 |
| Gabapentin | 20 | $120 |
| Meloxicam | 68 | $118 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Hollywood
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
- David BacksteinNaples$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.